中文 | English
Return
Total: 3 , 1/1
Show Home Prev Next End page: GO
MeSH:(Adenocarcinoma/*drug therapy/*genetics/mortality)

1.Influence of Different Therapies on EGFR Mutants by Circulating Cell-free DNA of Lung Adenocarcinoma and Prognosis.

Fei SU ; Ke ZHENG ; Yiyun FU ; Qian WU ; Yuan TANG ; Weiya WANG ; Lili JIANG

Chinese Journal of Lung Cancer 2018;21(5):389-396

2.Pharmacogenomic Assessment of Outcomes of Pemetrexed-Treated Patients with Adenocarcinoma of the Lung.

Minkyu JUNG ; Chul Ho LEE ; Hyung Soon PARK ; Ji Hyun LEE ; Young Ae KANG ; Se Kyu KIM ; Joon CHANG ; Dae Joon KIM ; Sun Young RHA ; Joo Hang KIM ; Byoung Chul CHO

Yonsei Medical Journal 2013;54(4):854-864

3.Transglutaminase 2 Expression Predicts Progression Free Survival in Non-Small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.

Jae Heon JEONG ; Byoung Chul CHO ; Hyo Sup SHIM ; Hye Ryun KIM ; Sun Min LIM ; Se Kyu KIM ; Kyung Young CHUNG ; S M Bakhtiar Ul ISLAM ; Jae Jin SONG ; Soo Youl KIM ; Joo Hang KIM

Journal of Korean Medical Science 2013;28(7):1005-1014

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 3 , 1/1 Show Home Prev Next End page: GO